Abstract
The underlying premise of structural biology is that the fundamental understanding of biological functions lies in the three-dimensional structures of proteins and other biopolymers. The two well-established experimental methods for determining the high-resolution structures of proteins have both contributed to the wealth of structural information available for the tumor suppressor genes. The tumor suppressor proteins whose structures have been determined by nuclear magnetic resonance (NMR) spectroscopy are listed in Table 1. Although X-ray crystallography plays a central role in high-throughput structure determination in the current structural genomics efforts, several features of NMR spectroscopy make it extremely well suited for three-dimensional structure determination as well as for the structure-function analysis of proteins (1,2).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Montelione, G. T., Zheng, D., Huang, Y. J., Gunsalus, K. C., and Szyperski, T. (2000) Protein NMR spectroscopy in structural genomics. Nature Struct. Biol., Struct. Genomics Suppl. 7, 982–985.
Wuthrich, K. (1998) The second decade into the third millenium. Nat. Struct. Biol., NMR Suppl. 5, 492–495.
Marassi, F. M. and Opella, S. J. (1998) NMR structural studies of membrane proteins. Curr. Opin. Struct. Biol. 8, 640–648.
Opella, S. J., Ma, C., and Marassi, F. M. (2001). NMR of membrane associated peptides and proteins, Meth. Enzymol. 339, in press.
Schuker, S. B., Hajduk, P. J., Meadows, R. P., and Fesik, S. W. (1996) Discovering high affinity ligands for proteins: SAR by NMR. Science 274, 1531–1534.
Moore, J. M. (1999) NMR screening in drug discovery. Curr. Opin. Biotechnol. 10, 54–58.
Clore, G. M. and Gronenborn, A. M. (1997) NMR structures of proteins and protein complexes beyond 20,000 Mr. Nat. Struct. Biol. NMR Suppl. 4, 849–853.
Gardner, K. H. and Kay, L. E. (1998) The use of 2H, 13C, 15N multidimensional NMR to study the structure and dynamics of proteins. Annu. Rev. Biophys. Biomol. Struct. 27, 357–406.
Pervushin, K., Riek, R., Wider, G., and Wuthrich K. (1997) Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl. Acad. Sci. USA 94, 12366–12371.
Veglia, G. and Opella, S. J. (2000) Lanthanide ion binding to adventitious sites aligns membrane proteins in micelles for solution NMR spectroscopy. J. Am. Chem. Soc. 122, 11733–11734.
Ma, C. and Opella, S. J. (2000) Lanthanide ions bind specifically to an added EF-hand and orient a membrane protein in micelles for solution NMR spectroscopy. J. Magn. Reson. 146, 381–384.
Wuthrich, K. (1986) NMR of Proteins and Nucleic Acids. Wiley, New York.
Clore, G. M. and Gronenborn, A. M. (1989) Determination of three-dimensional structures of proteins and nucleic acids in solution by nuclear magnetic resonance spectroscopy. Crit. Rev. Biochem. Mol. Biol. 24, 479–564.
Kigawa, T., Yabuki, T., Yoshida, Y., et al. (1999) Cell-free production and stable-isotope labeling of milligram quantities of proteins. FEBS Lett. 442, 15–19.
Studier, F. W. and Moffat, B. A. (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189, 113–130.
Edwards, A. M., Arrowsmith, C. H., Christendat, D., et al. (2000) Protein production:feeding the crystallographers and NMR spectroscopists. Nat. Struct. Biol. Struct. Genomics Suppl. 7, 970–972.
Ikura, M., Krinks, M., Torchia, D. A., and Bax, A. (1990) An efficient NMR approach for obtaining sequence-specific resonance assignments of larger proteins based on multiple isotopic labeling. FEBS Lett. 266, 155–158.
Ikura, M., Kay, L. E., and Bax, A. (1990) A novel approach for sequential assignment of 1H, 13C, and 15N spectra of proteins: heteronuclear triple-resonance three-dimensional NMR spectroscopy. Application to calmodulin. Biochemistry 29, 4659–4667.
Moseley, H. N. and Montelione, G. T. (1999) Automated analysis of NMR assignments and structures for proteins. Curr. Opin. Struct. Biol. 9, 635–642.
Wishart, D. S., Sykes, B. D., and Richards, F. M. (1991) Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J. Mol. Biol. 222, 311–333.
Wishart, D. S., Sykes, B. D., and Richards, F. M. (1992) The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31, 1647–1651.
Tolman, J. R., Flanagan, J. M., Kennedy, M. A., and Prestegard, J. H. (1995) Nuclear magnetic dipole interactions in field-oriented proteins: information for structure determination in solution. Proc. Natl. Acad. Sci. USA 92, 9279–9283.
Tjandra, N., Grzesiek, S. and Bax, A. (1996) Magnetic field dependence of nitrogen-proton J splittings in 15N-enriched human ubiquitin resulting from relaxation interference and residual dipolar coupling. J. Am. Chem. Soc. 118, 6264–6272.
Tjandra, N. and Bax, A. (1997). Direct measurement of distances and angles in biomolecules by NMR in a dilute liquid crystalline medium. Science 278, 1111–1114.
Sass, J., Cordier, F., Hoffmann, A., et al. (1999) Purple membrane induced alignment of biological macromolecules in the magnetic field. J. Am. Chem. Soc. 121, 2047–2055.
Hansen, M. R., Mueller, L., and Pardi, A. (1998) Tunable alignment of macromolecules by filamentous phage yields dipolar coupling interactions. Nat. Struct. Biol. 5, 1065–1074.
Clore, G. M., Starich, M. R., and Gronenborn, A. M. (1998) Measurement of residual dipolar couplings of macromolecules aligned in the nematic phase of a colloidal suspension of rod-shaped viruses. J. Am. Chem. Soc. 120, 10571–10572.
Brunger, A. T., Adams, P. D., Clore, G. M., et al. (1998) Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D54, 905–921.
Prestegard, J. H. (1998) New techniques in structural NMR—anisotropic interactions. Nat. Struct. Biol. NMR Suppl. 5, 517–522.
Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323–331.
Arrowsmith, C.H. (1999) Structure and function of the p53 family. Cell Death Diff. 6, 1169–1173.
Mulder, F. A., Ayed, A., Yang, D., Arrowsmith, C. H., and Kay, L. E. (2000) Assignment of 1H(N), 15N, 13C(alpha), 13CO and 13C(beta) resonances in a 67 kDa p53 dimer using 4D-TROSY NMR spectroscopy. J. Biomol. NMR 18, 173–176.
Cho, Y., Gorina, S., Jeffrey, P. D., and Pavletich, N. P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346–355.
orina, S. and Pavletich, N. P. (1996) Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274, 1001.
Kussie, P. H., Gorina, S., Marechal, V., et al. (1996). Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274, 948–953.
Stoll, R., Renner, C., Hansen, S., et al. (2001) Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53. Biochemistry 40, 336–344.
Wong K. B., DeDecker, B. S., Freund, S. M., Proctor M. R., Bycroft M., and Fersht A. R. (1999) Hot-spot mutants of p53 core domain evince characteristic local structural changes. Proc. Natl. Acad. Sci. USA 96, 8438–8442.
Lee, W., Harvey, T. S., Yin, Y., Yau, P., Litchfield, D., and Arrowsmith C. H. (1994) Solution structure of the tetrameric minimum transforming domain of p53. Nat. Struct. Biol. 1, 877–890.
Clore, G. M., Ernst, J., Clubb, R., et al. (1995) Refined solution structure of the oligomer-ization domain of the tumour suppressor p53. Nat. Struct. Biol. 2, 321–333.
Kuszewski, J., Gronenborn, A. M., and Clore, G. M. (1999) Improving the packing and accuracy of NMR structure with a pseudopotential for the radius of gyration. J. Am. Chem. Soc. 121, 2337–2338.
Jeffrey, P. D., Gorina, S., and Pavletich, N. P. (1995) Crystal structure of the tetramerization domain of the P53 tumor suppressor at 1.7 angstroms. Science 267, 1498.
Mittl, P. R., Chene, P., and Grutter, M. G. (1998) Crystallization and structure solution of p53 (residues 326-356) by molecular replacement using an NMR model as template. Acta Crystallogr. D54, 86–89.
Pietenpol, J. A., Tokino, T., Thiagalingam, S., El-Deiry, W. S., Kinzler, K. W., and Vogelstein, B. (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci USA 91, 1998–2002.
McCoy, M., Stavridi, E. S., Waterman, J. L., Wieczorek, A. M., Opella, S. J., and Hala-zonetis, T. D. (1997) Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain. EMBO J. 16, 6230.
Rustandi, R.R., Drohat, A.C., Baldisseri, D.M. Wilder, P.T., and Weber, D.J. (1998) The Ca(2+)-dependent interaction of S100B(βββ) with a peptide derived from p53. Biochemistry 37, 1951–1960.
Rustandi, R. R., Baldisseri, D. M., and Weber D. J. (2000) Structure of the negative regulatory domain of p53 bound to S100B(PP). Nat. Struct. Biol. 7, 570–574.
Baudier, J., Delphin, C, Grunwald D, Khochbin, S., and Lawrence, J. J. (1992) Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc. Natl. Acad. Sci. USA 89, 11627–11631.
Delphin, C, Ronjat, M., Deloulme, J. C, et al. (1999) Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53. J. Biol. Chem. 274, 10539–10544.
Scotto, C, Deloulme, J. C, Rousseau, D., Chambaz, E., and Baudier, J. (1998) Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis. Mol. Cell Biol. 18, 4272–4281.
Hannon, G. J. and Beach, D. (1994) p15 INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371, 257–261.
Serrano, M., Hannon, G. J., and Beach, D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD0CDK4. Nature 366, 704–707.
Guan, K. L., Jenkins, C. W, Li, Y., et al. (1994) Growth suppression by p18, a p16 INK40MTS1-and p14 INK4B0MTS2—related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8, 2939.
Guan, K. L., Jenkins, C. W, Li, Y., et al. (1996) Isolation and characterization of p19 INK4d, a p16-related inhibitor specific to CDK6 and CDK4. Mol. Biol. Cell. 7, 57–70.
Luh, F. Y, Archer, S. J., Domaille, P. J., et al. (1997) Structure of the cyclin-dependent kinase inhibitor p19 INK4d. Nature 389, 999–1003.
Baumgartner, R., Fernandez-Catalan, C, Winoto, A., Huber, R., Engh, R. A., and Holak, T. A. (1998) Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a. Structure 6, 1279–1290.
Li, J., Byeon, I. J. Ericson, K., Poi, M. J., O’Maille, P., Selby, T., and Tsai M. D (1999) Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A. Biochemistry 38, 2930–2940.
Venkataramani, R., Swaminathan, K., and Marmorstein, R. (1998) Crystal structure of the CDK406 inhibitory protein p18 INK4c provides insights into ankyrin-like repeat structure/function and tumor-derived p16 INK4 mutations. Nat. Struct. Biol. 5, 74–81.
Byeon, I. J., Li, J., Ericson, K., et al. (1998) Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol. Cell 1, 421–431.
Yuan, C, Selby, T. L., Li, J., Byeon, I. J., and L. Tsai, M. D. (2000) Tumor suppressor INK4: refinement of p16INK4A structure and determination of p15INK4B structure by comparative modeling and NMR data. Protein Sci. 9, 1120–1128.
Laity, J. H., Chung, J., Dyson, H. J., and Wright, P. E. (2000) Alternative splicing of Wilms’ tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes. Biochemistry 39, 5341–5348.
Laity, J. H., Dyson, H. J., and Wright, P. E. (2000) DNA-induced alpha-helix capping in conserved linker sequences is a determinant of binding affinity in Cys(2)-His(2) zinc fingers. J. Mol. Biol. 295, 719–727.
Botuyan, M.V., Koth, C.M., Mer, G., et al. (1999) Binding of elongin A or a von Hippel-Lindau peptide stabilizes the structure of yeast elongin C. Proc. Natl. Acad. Sci. USA 96, 9033–9038.
Davison, T. S., Nie, X., Ma, W., et al. (2001) Structure and functionality of a designed p53 dimer. J. Mol. Biol. 307, 605–617.
Chi, S.-W., Ayed, A., and Arrowsmith, C. H. (1999) Solution structure of a conserved C-terminal domain of p73 with structural homology to the Sam domain. EMBO J. 18, 4438–4445.
Polshakov, V. I., Williams, M. A., Gargaro, A. R., et al. (1997) High-resolution solution structure of human pNR-2/pS2: a single trefoil motif protein. J. Mol. Biol. 267, 418–432.
Williams, M. A., Westley, B. R., May, F. E. B., and Feeney, J. (2001) The solution structure of the disulphide-linked homodimer of the human trefoil protein TFF1. FEBS Lett. 493, 70–74.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Marassi, F.M. (2003). Utilizing NMR to Study the Structure of Growth-Inhibitory Proteins. In: El-Deiry, W.S. (eds) Tumor Suppressor Genes. Methods in Molecular Biology™, vol 223. Humana Press. https://doi.org/10.1385/1-59259-329-1:3
Download citation
DOI: https://doi.org/10.1385/1-59259-329-1:3
Publisher Name: Humana Press
Print ISBN: 978-0-89603-987-2
Online ISBN: 978-1-59259-329-3
eBook Packages: Springer Protocols